| Registro completo |
| Provedor de dados: |
AgEcon
|
| País: |
United States
|
| Título: |
COMPETITIVE STRATEGIES OF BIOTECHNOLOGY FIRMS: IMPLICATIONS FOR U.S. AGRICULTURE
|
| Autores: |
Begemann, Brett D.
|
| Data: |
2003-01-29
|
| Ano: |
1997
|
| Palavras-chave: |
Biotechnology
Monsanto
Strategies
Research and Development/Tech Change/Emerging Technologies
|
| Resumo: |
The agricultural biotechnology industry has evolved from a focus on outstanding science to a more mature phase where firms focus on near-term products and building businesses. Understanding complex relationships and distribution channels and a global perspective are crucial to commercialization. Yet, leading-edge technology and early identification of key traits will be critical to developing superior products that ensure competitiveness in the marketplace. Monsanto is organizing around a life sciences model where seed, crop chemicals, pharmaceuticals, and food ingredient businesses will exploit mutual synergies driven by basic science and discovery.
|
| Tipo: |
Journal Article
|
| Idioma: |
Inglês
|
| Identificador: |
6940
http://purl.umn.edu/15540
|
| Editor: |
AgEcon Search
|
| Relação: |
Journal of Agricultural and Applied Economics>Volume 29, Number 01, July 1997
|
| Formato: |
6
application/pdf
|
|
